Skip to main content
Sale!

CJC 1295 no dac + Ipamorelin 5mg/5mg

Original price was: $89.00.Current price is: $85.00.

CJC-1295 (No DAC) + Ipamorelin 5mg/5mg peptide blend for in vitro studies.

VialsQuantityDiscount
First Research2 5%
Most Popular3 10%
Max Savings4 - 9 15%
Purchase & earn 85 points!
Category:

Description

CJC-1295 (No DAC) + Ipamorelin | 5mg/5mg Blend

For In Vitro Research Use Only – Not for Human or Veterinary Use

 

Specifications:
  • Quantity: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin (Total: 10mg)
  • Form: Lyophilized Powder
  • Purity: ?98% (HPLC Verified)
Intended Use:

For laboratory research use only. Not for human or animal use. Not intended for consumption, diagnostics, or therapeutic applications.

Disclaimer:

This compound has not been evaluated by the FDA. No claims are made regarding its use for any medical purpose. All use must comply with applicable research and safety guidelines.

Terms of Sale:

All sales by Onyx Research are final. Buyer confirms they are a qualified laboratory researcher and assumes responsibility for safe handling and lawful use.

There are no reviews yet.

Be the first to review “CJC 1295 no dac + Ipamorelin 5mg/5mg”

Your email address will not be published. Required fields are marked *

Related products

FDA Disclaimer

The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.

Onyx Research is a chemical supplier. Onyx Research is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Onyx Research is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.

THE PRODUCTS WE OFFER ARE NOT INTENDED FOR HUMAN USE. THEY ARE INTENDED FOR IN-VITRO AND PRE-CLINICAL RESEARCH PURPOSES ONLY. THE CUSTOMER ACKNOWLEDGES THAT THERE ARE RISKS IN THE HANDLING, USE, AND DISTRIBUTION OF THESE PRODUCTS, AND CERTIFIES THAT IT HAS THE PROPER EQUIPMENT, FACILITIES, AND PERSONNEL FOR MANAGING THOSE RISKS; AND THE CUSTOMER KNOWINGLY ACCEPTS THESE RISKS.